Comparing the effects of three therapeutic regimens prednisolone on platelet increase in patients with primary immune thrombocytopenic purpura
Phase 3
- Conditions
- primary immune thrombocytopenia purpura.Other coagulation defects
- Registration Number
- IRCT20230717058813N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
age of 18-60 years,
having a normal spleen size
suffering from Immune thrombocytopenia (ITP)
Exclusion Criteria
history of chronic kidney diseases
history of diabetes
pregnant women or pregnancy during study
history of secondary Immune thrombocytopenia (ITP) such as (Antiphospholipid syndrome, Myelodysplastic syndromes and vasculitis)
patients under treatment with any drugs within 3-month before participating in study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet value in cell blood count test. Timepoint: Monthly. Method of measurement: Cell blood count test.
- Secondary Outcome Measures
Name Time Method Side effect of treatment with corticosteroids. Timepoint: Six-months after treatment. Method of measurement: Clinical visit.